Radient Technologies Inc. filing application for Controlled Drugs
and Substances Dealers license to serve the Cannabinoids Medical
Market
November 14, 2016
EDMONTON, ALBERTA (November 14, 2016 -- InvestorsHub Newswire) -
Radient Technologies Inc. ("Radient" or the Company) (TSX Venture:
RTI),
with its proprietary Microwave-Assisted Processing (MAP) technology
and, its related expertise in natural product extraction,
purification and isolation, is pleased to announce its foray in the
fast emerging cannabinoids medical market. Radients MAP technology
has applications across a wide range of industry verticals, which
includes pharmaceuticals, nutritional supplements, food and
beverage, cosmetics, tobacco and now - of increasing relevance -
the fast growing cannabinoids market.
Radient is currently taking advantage of its superior extraction
technology to establish itself as a leading North American player,
capturing value in the medical cannabinoids market extracted from
both marijuana and hemp. There is a latent need to extract
cannabinoids with a higher efficiency and purity to create value
and meet strict Quality Assurance standards as the regulatory
environment changes.
Radient, with its unique MAP technology, has the potential to
supply the cannabinoids industry with hemp extracts standardized to
specific concentrations of cannabinoids while meeting regulatory
standards with less than 0.3% tetrahydrocannabinol (THC). Further,
Radients full-scale, GMP-certified facility will allow the Company
to easily capitalize on the industrys desire to partner with a
reputable extraction expert to offer product manufacturing under
strict Quality Assurance and Quality Control while possessing the
capacity necessary to meet growing demand for standardized hemp
extracts and marijuana concentrates.
As a part of these regulatory changes and demand pressures,
Radient has requested proper accreditation and permits from the
Canadian Government for conducting research and the eventual
commercial production of standardized cannabinoids extracts. The
Companys application for a Controlled Drugs and Substances Dealers
license is currently being prepared for submission and will be
followed by partnerships with leading suppliers of hemp and
marijuana biomass.
Radient will be participating at the Canadian Hemp Trade
Alliance (CHTA) Conference in Saskatoon and the Marijuana Business
Conference & Expo in Las Vegas both during the week of November
14 to meet with potential suppliers and customers.
About Radient
Radient extracts natural compounds from a range of biological
materials using microwave assisted processing ("MAP"), a patented
technology platform which provides superior customer outcomes in
terms of ingredient purity, yield, and cost. From its 20,000 square
foot manufacturing plant in Edmonton, Alberta, Radient serves
market leaders in industries that include pharmaceutical, food,
beverage, natural health, personal care and biofuel markets. Visit
www.radientinc.com for more information.
Contacts
Denis Taschuk, Chief Executive Officer, dtaschuk@radientinc.com,
(780) 465-1318
Prakash Hariharhan, Chief Financial Officer,
mcabigon@radientinc.com, (780) 465-1318
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.